Table 1. Demographic data of the 118 patients presenting with colorectal or pancreatic cancer, according to the occurrence or not of a thrombo-embolic event.
Group A | Group B | ||
---|---|---|---|
Thrombo-embolic event | No thrombo embolic event | ||
n | 19 | 99 | P value |
Gender | 0.79 | ||
Male | 12 (63) (a) | 67 (68) | |
Female | 7 (37) | 31 (32) | |
Age (years) | 69 [54–89] (b) | 71 [29–93] | 0.32 |
Colorectal cancer | 10 (53) | 74 (75) | |
TNM stage (c) | |||
0 | - | 6 (8) | 0.89 |
I | 2 (20) | 17 (23) | |
II | 3 (30) | 22 (30) | |
III | 3 (30) | 17 (23) | |
IV | 2 (20) | 12 (16) | |
Pancreatic cancer | 9 (47) | 25 (25) | |
TNM stage | |||
I | - | 1 (4) | 0.19 |
II | 7 (78) | 12 (48) | |
III | - | 2 (8) | |
IV | 1 (11) | 7 (28) | |
NA | 1 (11) | 3 (12) |
(a): number (percentage); (b): median (range); (c): TNM, i.e. Tumor Node Metastasis, classification includes stages I and II for localized tumor, III for locally advanced and IV for metastatic tumor; NA: not available; p<0.05 is considered as significant.